Alligator Bioscience presents at the H.C. Wainwright Annual Global Life Sciences Conference
Lund, Sweden, 5 April – Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, announced today that it will be featured as a presenting company at the H.C. Wainwright Annual Global Life Sciences Conference. The conference is being held on April 8-10 at the Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco. CEO Per Norlén will provide an overview of the Company's business during the live presentation and will be available to participate in one-on-one meetings with investors who are registered